Kiniksa Pharmaceuticals International, plc KNSA Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on trailing twelve months.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's return on assets?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported return on assets of 10.3% in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's return on assets changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's return on assets increased by 438.6% year-over-year, from -3% to 10.3%.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's return on assets?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's return on assets has grown at a -30.3% compound annual growth rate (CAGR), from -53.4% to 8.8%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.